Leadership & Pay ·
On July 15, 2026, ARS Pharmaceuticals, Inc. announced the immediate resignation of Board member Richard Lowenthal and…
SPRYARS Pharmaceuticals, Inc.
On July 15, 2026, ARS Pharmaceuticals, Inc. announced the immediate resignation of Board member Richard Lowenthal and the termination of Chief Medical Officer Sarina Tanimoto, M.D., without cause. The company agreed to pay Mr. Lowenthal and Dr. Tanimoto one-time bonus payments of $217,350 and $111,780, respectively, subject to a release of claims. ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for gastrointestinal diseases.